Is AI superintelligence inevitable? AI safety researcher David Krueger says it doesn’t have to be. Krueger, an assistant ...

David Krueger says AI’s integration into warfare makes international agreements halting development ever more urgent.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Economics is ultimately about production and distribution, and both are being reshaped by artificial intelligence. As AI advances rapidly, it is becoming ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Rajeev Dhir is a writer with 10+ years of experience as a journalist with a background in broadcast, print, and digital newsrooms. Ryan Eichler holds a B.S.B.A with a concentration in Finance from ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...